Source Details
View detailed information about this source submission and its extracted claims.
Pharmaceutical companies increased lobbying spending in the first quarter of 2024. Key issues driving the spending include 340B program reform, supply chain issues, and pharmacy benefit manager regulations. The article also covers Supreme Court arguments on abortion and bird flu fragments in milk.
AI Extracted Information
Automatically extracted metadata and content analysis.
- AI Headline
- Pharma lobbying up in 2024
- Simplified Title
- Pharma Companies Increase Lobbying Spending in 2024
- AI Excerpt
- Pharmaceutical companies increased lobbying spending in the first quarter of 2024. Key issues driving the spending include 340B program reform, supply chain issues, and pharmacy benefit manager regulations. The article also covers Supreme Court arguments on abortion and bird flu fragments in milk.
- Subject Tags
-
Pharmaceuticals Lobbying Healthcare Policy Abortion Bird Flu Medicare Supreme Court
- Context Type
- News
- AI Confidence Score
-
1.000
- Context Details
-
{ "tone": "informative", "perspective": "neutral", "audience": "specialized", "credibility_indicators": [ "expert_quotes", "data_cited", "reporting" ] }
Source Information
Complete details about this source submission.
- URL
- https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996
- Overall Status
-
Completed
- Submitted By
- Donato V. Pompo
- Submission Date
- August 10, 2025 at 6:04 PM
- Metadata
-
{ "source_type": "extension", "content_hash": "48f3fb6fb445518b3e04bb2d393d6720c1c394d859c98d7bba4a0952e873644e", "submitted_via": "chrome_extension", "extension_version": "1.0.18", "parsed_content": "Print\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Chelsea is a reporter at POLITICO, with a focus on HHS. She also co-authors Pulse, POLITICO's flagship morning health newsletter. She's been a health care reporter since 2019, having started her career at Inside Health Policy. She previously worked for U.S. News & World Report and Axios. She is also an adjunct journalism professor at the University of Maryland and her alma mater, American University, which she graduated from in 2017 with a degree in communications.\n \n \n \n \n \n \n \n \n \n Ben is a congressional reporter at POLITICO, focusing on domestic policy, with an emphasis on the House Energy and Commerce Committee and related Senate committees including the Senate Commerce Committee and the Senate Committee on Health, Education, Labor and Pensions.His coverage on policy issues is read closely by policymakers and company executives.He's spent years covering the ins and outs of health care policy on Capitol Hill, breaking a steady stream of scoops on key policy developments, bringing readers inside closed-door negotiations and private agency rulemaking. He has broken news that has led federal agencies to restructure, prompted legislation and been cited in investigations in Congress.He's covered how lawmakers plan to enact President-elect Donald Trump's domestic agenda in his second term, how Congress has transitioned from pandemic-era health policies, and how innovation has disrupted the health care industry and beyond.Reach him at bleonard@politico.com.At POLITICO, he previously authored POLITICO\u2019s flagship Pulse health care newsletter and covered breaking news.He loves to cycle and golf in his free time and as a Bay Area native, is a loyal San Francisco Giants fan. He\u2019s a graduate of Duke University, where he studied public policy and journalism, and was managing editor of the Duke Chronicle.\n \n \n \n \n \n \n \n \n \n \n \n \n \n Friday,\n \n 8\/8\/25\n \n \n \n \n \n \n \n \n \n \n Thursday,\n \n 8\/7\/25\n \n \n \n \n \n \n \n \n \n \n Wednesday,\n \n 8\/6\/25\n \n \n \n \n \n \n \n \n \n \n Tuesday,\n \n 8\/5\/25\n \n \n \n \n \n \n \n \n \n \n Monday,\n \n 8\/4\/25\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Pharma lobbying up in 2024\n \n \n \n \n \n \n By CHELSEA CIRRUZZO and BEN LEONARD\u00a0\n04\/24\/2024 10:00 AM EDT\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Drugmakers ramped up their K Street spending this year. | J. Scott Applewhite\/AP\n \n \n \n \nDRUGMAKERS DOMINATE TOP LOBBYING SPENDERS \u2014 The pharmaceutical industry bolstered its lobbying spending in the first three months of 2024 compared with the same period in 2023, according to newly filed disclosures, POLITICO\u2019s Megan R. Wilson reports.Crunching the numbers: Megan found that 17 of the 29 pharmaceutical companies and groups that spent $500,000 or more in the first quarter boosted their advocacy dollars this year.For example, industry group PhRMA\u2019s advocacy spending grew 20 percent in Q1 2024 compared with Q1 2023. Novartis spent 44 percent more on lobbying last quarter than in 2023, surging into the top 10 health lobbying spenders for the first time in years.Neither would comment about what drove the increases, but disclosures note the industry was working on a number of issues advancing in Congress \u2014 including reforming the 340B discount drug program, alleviating supply chain issues and reining in pharmacy benefit managers, which negotiate discounts on drugs and choose which medicines insurance plans will cover.Momentum behind PBM policy has prompted lobbying boosts over the last several quarters, but it came to a head during negotiations over a pair of March government funding bills when some lawmakers pushed for policies to change how PBMs operate \u2014 a major policy goal for drug manufacturers that\u2019s garnered bipartisan support in Congress.As a result, the Pharmaceutical Care Management Association, which represents PBMs, increased its lobbying spending by 74 percent compared with last year. Negotiations over policy riders, including PBM reforms, ultimately fell apart.\u201cCongress rightly declined to rush through misguided policies targeting pharmacy benefits,\u201d said Katie Payne, a spokesperson for the group, which argues its members drive medicine costs down.However, another showdown on Capitol Hill over the policies is likely, so this could be just the beginning.Here are the top 10 health care lobbying spenders in the first quarter of 2024 versus the same period a year ago.PhRMA: $9.6 million vs. $7.99 million The American Medical Association: $7.28 million vs. $6.7 million The American Hospital Association: $6.01 million vs. $5.61 million PCMA: $4.8 million vs. $2.76 millionAARP: $4.37 million vs. 3.85 million AHIP: $4.21 million vs. $4.74 millionPfizer: $3.55 million vs. $4.6 millionNovartis: $3.51 million vs. $2.44 millionGenentech: $3.34 million vs. $3.1 million Amgen: $3.33 million vs. $2.8 millionWELCOME TO WEDNESDAY PULSE. D.C. readers: How were you affected by the Great Foxtrot Closure of 2024? For me, that means finding a new spot for source coffees! Want to grab coffee and talk about health policy with us? Email us at ccirruzzo@politico.com and bleonard@politico.com and follow along @ChelseaCirruzzo and @_BenLeonard_.\n \n \n \n \n \n \n \n \n \n \n \n \n The Supreme Court will hear arguments today on whether Idaho's abortion ban is constitutional. | Andrew Caballero-Reynolds\/AFP via Getty Images\n \n \n \n \nEMERGENCY ABORTIONS BEFORE HIGH COURT \u2014 The U.S. Supreme Court justices who overturned Roe said at the time that it wasn\u2019t appropriate for \u201cunelected members of this Court\u201d to \u201coverride the democratic process\u201d and set national abortion law.But that\u2019s exactly what they\u2019re poised to do, again, with a case they\u2019re hearing Wednesday on whether hospitals that take Medicare can turn away pregnant patients who need an emergency abortion, POLITICO\u2019s Alice Miranda Ollstein and Josh Gerstein report.The arguments will focus on the tension between a Reagan-era federal law mandating emergency treatment, including abortion, and Idaho\u2019s push to enforce its near-total prohibition on the procedure, including in medical emergencies. The Biden administration says the law requires doctors to perform abortions to stabilize patients in crisis.Idaho officials argue that the Biden administration\u2019s interpretation of the Emergency Medical Treatment and Labor Act, known as EMTALA, undermines the state\u2019s ban and would make it too easy for patients to get a medically unnecessary abortion. The federal government counters that EMTALA\u2019s protections preempt state law and prevent patient dumping by unscrupulous hospitals.Health and legal experts also warn that a ruling for Idaho could encourage states and individual hospitals around the country to test the bounds of EMTALA for care unrelated to abortion.\u201cIf Idaho was allowed to do what it wants to do, then essentially that is green-lighting states to go after EMTALA for any disfavored population, or treatment or condition,\u201d warned Sara Rosenbaum, the founding chair of the Department of Health Policy at George Washington University, on a call with reporters last week.\u201cWhether it is barring all but terminal emergency care for people with HIV-AIDS, whether it is barring all but terminal emergency care for people who\u2019ve been in auto accidents on the grounds that somehow having access to an emergency department encourages unsafe driving, the list goes on and on and on,\u201d she added.\nBIRD FLU FRAGMENTS IN MILK \u2014 The FDA said Tuesday evening that the commercial milk supply is safe after industry groups told lawmakers on Capitol Hill that bird flu virus fragments have been detected in retail milk samples, according to three people familiar with the matter, POLITICO\u2019s Meredith Lee Hill reports.The FDA confirmed \u201csome of the samples collected have indicated the presence\u201d of bird flu \u201cparticles\u201d under certain testing, but the agency maintained that \u201cpasteurization is likely to inactivate the virus.\u201dThe FDA said it would make additional test results available in the coming days.Trade groups quickly mobilized to reiterate the FDA\u2019s assessment that commercial milk is safe, following a report from The Washington Post on the viral detection.The National Milk Producers Federation said in a statement that \u201cviral fragments detected after pasteurization are nothing more than evidence that the virus is dead; they have zero impact on human health.\u201dAs of Tuesday, avian flu had been detected in 33 dairy herds across eight states, according to the latest USDA data.\nMORE WEGOVY COVERAGE \u2014 One in 4 Medicare beneficiaries who are overweight or obese might be eligible for coverage of Wegovy now that it\u2019s approved to reduce heart attack and stroke risk, according to a KFF analysis out today. The FDA approved Novo Nordisk\u2019s weight-loss drug Wegovy earlier this year to reduce the risk of major cardiovascular deaths in people with heart disease. CMS followed up by announcing in March that Medicare would reimburse older Americans prescribed Wegovy under those conditions.According to a KFF analysis of 2020 data, 3.6 million people on Medicare could be eligible for coverage of Wegovy. Twenty percent of Medicare beneficiaries, or 10 million people, had cardiovascular disease in 2020, while 27 percent, or 13.7 million people, were obese or overweight.Despite the huge popularity of weight-loss drugs, Medicare is prohibited by law from covering them solely for obesity.How it could impact spending: The KFF analysis says Medicare spending impacts depend on how Part D plans add coverage for Wegovy, the extent of prior authorization and the number of people who use the drug.Beneficiaries could face out-of-pocket costs of $325-$430 a month if they have to pay a percentage of the drug\u2019s $1,300 list price \u2014 though the Part D out-of-pocket spending limit would restrict what beneficiaries pay in a year.\nHOSPITALS VS. NONCOMPETE RULE \u2014 Hospital groups are expected to challenge a Federal Trade Commission rule finalized Tuesday that bans noncompete agreements for all workers, POLITICO\u2019s Erin Schumaker reports.The rule declares noncompetes an unfair method of competition. Provisions in noncompete agreements bar or restrict workers from quitting and joining rivals, and hospitals have used them widely to prevent their doctors from leaving.Doctors will benefit from the decision since a large share of them \u2014 45 percent in group practices and likely many more in other areas of medicine \u2014 are bound by noncompetes. The rule will allow many of them to leave their jobs for rival organizations without penalty.Hospital groups, however, call the rule bad policy. House Republicans called it a \u201cpower grab\u201d and a \u201ctop-down, one-size-fits-all approach that violates basic American principles\u201d in a letter to FTC commissioners last year.What\u2019s next? The U.S. Chamber of Commerce and other groups are expected to sue, with the Chamber saying it would challenge the FTC\u2019s authority to issue the rule as soon as Wednesday.\nTeal Baker has joined the Better Medicare Alliance as chief operating officer. She previously served as executive vice president and chief operating officer at Invariant, a government relations firm.\nReuters reports on how doctors\u2019 skepticism is slowing prescriptions of the Alzheimer\u2019s drug Leqembi.STAT reports on the health policy issues a second Trump administration wants to put its stamp on.\n \n \n \n \n Amanda Chu @https:\/\/x.com\/amandalanchu\n Amanda Friedman @https:\/\/x.com\/amandasfriedman\n Lauren Gardner @Gardner_LM\n Sophie Gardner @sophie_gardnerj\n Kelly Hooper @kelhoops\n Robert King @rking_19\n Simon Levien @https:\/\/x.com\/simonjlevien\n David Lim @davidalim\n Alice Miranda Ollstein @aliceollstein\n Carmen Paun @carmenpaun\n Ruth Reader @RuthReader\n Erin Schumaker @erinlschumaker", "ai_headline": "Pharma lobbying up in 2024", "ai_simplified_title": "Pharma Companies Increase Lobbying Spending in 2024", "ai_excerpt": "Pharmaceutical companies increased lobbying spending in the first quarter of 2024. Key issues driving the spending include 340B program reform, supply chain issues, and pharmacy benefit manager regulations. The article also covers Supreme Court arguments on abortion and bird flu fragments in milk.", "ai_subject_tags": [ "Pharmaceuticals", "Lobbying", "Healthcare Policy", "Abortion", "Bird Flu", "Medicare", "Supreme Court" ], "ai_context_type": "News", "ai_context_details": { "tone": "informative", "perspective": "neutral", "audience": "specialized", "credibility_indicators": [ "expert_quotes", "data_cited", "reporting" ] }, "ai_source_vector": [ -0.009589121, -0.00027926627, 0.0024956907, -0.054454945, -0.0054307603, 0.001639773, -0.026273513, 0.04006247, -0.011948857, 0.013991365, -0.01077567, -0.0146280145, -0.0020541118, -0.006155207, 0.08888105, 0.016051924, -0.013557615, 0.003223489, 0.012417714, -0.0028889584, -0.005336629, 0.03432304, -0.017274303, -0.023407957, 0.014444345, -0.0015792479, 0.017193208, 0.009462208, 0.030804982, 0.0005724702, -0.030866206, 0.013762751, 0.019630596, 0.0151066445, 0.020522574, 0.017623337, 0.01923672, -0.01889938, -0.01124354, 0.033786096, 0.01363483, 0.015625026, 0.011819885, 0.007532282, 0.008899593, -0.0074337847, 0.014878651, -0.038621817, -0.009175855, 0.031714767, -0.020286158, -0.00036463016, -0.029735576, -0.16558552, -0.013525102, 0.017678518, -0.003293926, -0.0009764448, 0.009828444, -0.02118223, -0.011489558, 0.011196491, -0.025086274, -0.03650207, 0.0056086653, -0.020425206, 0.004403833, 0.012045766, -0.0034770968, -0.034793686, 0.008510131, 0.02154419, 0.0010768875, -0.013817155, -0.02255819, -0.010199041, 0.01916631, 0.029406527, -0.0095708715, -0.0009901731, -0.013231411, 0.021782894, -0.022466015, -0.028413102, 0.016394136, -0.028581752, -0.0011847867, -0.022258682, 0.009646491, -0.0060483385, -0.001365618, 0.024412917, 0.005900393, -0.010609184, -0.015551255, 0.009521948, 0.0069032563, -0.0030431724, -0.0032672633, 0.006862023, 0.009590856, -0.008320094, 0.0017462659, -0.020059323, -0.01058865, -0.013433482, -0.018294813, -0.007364758, -0.019288734, 0.022641191, -0.0132410005, 0.0012916331, -0.01754431, 0.02967942, 0.0031066244, -0.15089276, 0.0040598675, 0.01433019, -0.008496363, -0.037460677, -0.009389226, -0.008337022, 0.006361745, 0.022053963, -0.0031482521, -0.009834876, -0.016682804, -0.0044142, 0.009137751, -0.00030306325, 0.0024440626, 0.0028112743, 0.0223759, -0.017454123, -0.012796029, 0.018713491, -0.0021658207, -0.0069594625, 0.00010114391, -0.0074035604, -0.0031250885, 0.026961684, -0.004401241, 5.9304995e-5, -0.00622323, 0.0014680781, -0.033252653, -0.0061867405, -0.008341567, 0.020202572, 0.011278146, 0.0066528195, 0.003212267, -0.0013393678, 0.0088603, 0.031336907, 0.005065927, -0.010652497, 0.0048952056, -0.006510485, -0.00961851, 0.02162418, 0.009689971, -0.0008635707, 0.013841675, 0.024269998, -0.0044578738, 0.01323311, 0.024449775, 0.0001375724, 0.0037547257, 0.0055073956, -0.0023439904, -0.009813193, -0.016621536, -0.015015637, 0.020610651, 0.0112395445, -0.00218025, 0.0018611776, 0.002433561, 0.014371858, 0.013648101, 0.005798297, 0.008911328, -0.0059363344, -0.014904105, -0.0042755893, -0.0059033697, 0.014062749, -0.02273649, -0.0160958, -0.0016163047, -0.017333103, 0.010036417, -0.010948575, -0.012154062, 0.010271, -0.0063565085, -0.00795429, 0.027357144, -0.005573245, 0.0037146655, -0.015142396, -0.0057796612, -0.011495092, -0.030202484, -0.005204198, 0.025703244, 0.011334965, -0.014312113, 0.007350617, 0.0014920592, -0.031296253, 0.03934888, -0.008603968, -0.017935779, 0.02847666, 0.007950614, -0.023710802, 0.022825615, -0.008846718, 0.00958117, 0.003140087, 0.017245715, 0.028488988, 0.022579947, -0.009438457, -0.0007493095, -0.008725834, 0.014356681, -0.0022669798, -0.0041937227, -0.0007011382, 0.014258188, -0.013009253, 0.01669695, 0.0048126914, 0.04866945, -0.0076072533, 0.00012966711, 0.006897644, -0.017537598, 0.016580176, 0.038253885, -0.0003437574, -0.0043297876, -0.030184114, -0.01409798, -0.010690753, -0.0006682396, 0.014365445, 0.018822439, -0.024651853, 0.011051893, 0.028913883, -0.009467892, -0.014905202, 0.0026274172, 0.012081154, -0.004210205, 0.011910811, -0.0027291034, -0.0068602785, 0.0019940345, -0.021531582, 0.020791767, -0.0036500157, -0.012215238, 0.0033717197, -0.014674682, 0.020624883, 0.012147765, -0.008553389, -0.00092237204, 0.004187708, -0.088656776, 0.01391318, 0.006409334, 0.0073552756, 0.02961663, 0.0027498892, -0.0028999378, 0.00411821, -0.001531146, -0.012005481, -0.003018442, -0.0129029695, -0.013615397, -0.028357347, -0.003575575, 0.0071978215, -0.024784697, -0.0049813567, 0.005691627, -0.010288866, 0.006546668, -0.0065425998, -0.020031001, -0.022683118, -0.00045786073, 0.014873827, 0.016862566, 0.04208514, 8.971753e-5, -0.004664759, -0.021122653, 0.009549287, 0.017967973, -0.0038569253, -0.012149512, 0.004596502, -0.024164146, -0.009220819, 0.028853383, -0.022945669, 0.011759155, 0.008848507, -0.0065330123, -0.0056564836, 0.004848699, 0.011013473, -0.015175625, 0.017979767, -0.029750468, -0.008108385, 0.011010597, 0.038917184, 0.011683746, -0.015981885, -0.013106962, -0.0052194777, -0.002255471, -0.0011678524, 0.030100625, 0.033499952, 0.0031044784, -0.00587553, 0.03235896, 0.010578667, 0.01974568, -0.010657734, -0.018953018, -0.013715236, 0.009294526, -0.0017804346, -0.009325916, -0.027400406, 0.0079861265, -0.023469979, 0.037785597, 0.01537674, 0.012235191, -0.017733302, -0.060503, -0.0040836413, 0.0050075077, 0.018607706, -0.010882831, 0.021161487, 0.0026003865, 0.0025215438, -0.015143739, -0.04243367, 0.0023601374, -0.035573382, -0.010251928, -0.0048883283, -0.012362467, -0.014539809, -0.024643246, 0.025739102, -0.018562151, 0.0015100816, 0.007233771, 0.0042804847, -0.005923633, 0.0015607491, -0.007428805, 0.0008691215, 0.0020764081, 0.0031969964, 0.023709144, 0.0062281936, 0.0042272797, 0.03512173, 0.020661158, -0.0027950748, 0.013928864, 0.027720619, -0.047026712, -0.021445237, -0.025592808, 0.0065723252, 0.0050071646, 0.001876261, 0.00040359367, -0.01047559, -0.011804591, 0.0044234707, 0.0038390695, 0.009069145, 0.0032852583, -0.003725428, 0.00029901444, -0.00051454105, -0.017507922, -0.015771046, -0.008224773, -0.0052821827, 0.0057067727, 0.006060667, 0.0043206206, -0.0018117162, -0.00038619258, -0.013206122, -0.03829694, 0.011357323, 0.016678456, 0.0034988434, 0.018276371, 0.021150062, -0.031536814, -0.003995751, 0.013495329, 0.006659032, -0.010892345, -0.03551317, -0.005529378, -0.0035876767, 0.010339711, 0.002244223, -0.01379539, -0.010004785, -0.021913102, -0.0233228, -0.015570643, -0.015906313, -0.0008501874, -0.011237555, -0.0050433856, 0.00774932, 0.019373212, 0.0022569539, 0.022692101, 0.020402938, -0.0049291085, -0.0038806694, -0.026570724, -0.010754647, -0.019153913, -0.017889472, 0.002859329, -0.014370601, -0.0017399961, 0.014185917, 0.008314863, -0.0019335353, -0.026929524, -0.020660218, 0.007970545, -0.02269099, -0.009378964, 0.009285198, -0.015957072, -0.0052500726, 0.029826105, -0.014130444, 0.0018448638, 0.023052802, 0.010267014, -0.00072520896, -0.010956653, 0.038064934, -0.0033291774, -0.01270893, 0.0009618467, -0.0049312655, 0.017130079, 0.014427157, 0.009660489, -0.029705124, -0.01566764, 0.0033995456, -0.0007601744, 0.025546016, 0.003273267, -0.006855662, -0.026821595, 0.0028681178, 0.021043308, 0.037839696, -0.010915901, -0.017470464, -0.024880575, 0.022090124, 0.0039355783, -0.016697448, 0.0056412285, -0.0063482756, 0.00050657365, 0.00025542086, 0.038634922, -0.011199521, -0.021984143, -0.015753275, -0.0020924637, -0.011607336, 0.015131956, 0.016130464, -0.020805847, 0.0315711, 0.001489437, 0.009196976, -0.0069362377, 0.008585956, -0.005494139, 0.030322623, -0.012347901, -0.010940313, 0.013093779, 0.03515262, -0.015263038, 0.008062798, -0.020731917, -0.015160856, 0.016067501, 0.010625114, 0.019605486, -0.006862553, -0.02259107, 0.036684692, 0.021008214, -0.041610282, -0.008366022, -0.013378891, 0.0058669336, 0.019771371, -0.012421358, 0.025749536, -0.016607985, 0.002196155, -0.020542394, -0.015667517, 0.005781453, -0.09120264, -0.010576831, 0.01090934, 0.0137447845, -0.0029645239, -0.023342907, -0.009024426, -0.025578845, 0.01687515, -0.004358929, -0.03135903, -0.014590617, -0.0108870305, 0.018343508, 0.0034851423, -0.0101531, -0.00065530074, 0.016084418, 0.015141976, 0.010781255, -0.005867109, -0.012383919, 0.009624003, -0.0060716043, -0.021718485, 0.0067356485, 0.013091723, -0.0014342576, 0.0057191877, -0.006723258, -0.0023949465, -0.008860128, 0.003435736, 0.037811715, -0.014194271, 0.00571397, -0.01643538, -0.011988442, 0.0044790655, 0.03386052, 0.00025919403, 0.0027335226, 0.008905425, -0.032915834, -0.010228033, -0.009612215, 0.0020770875, 0.0385433, 0.011053143, -0.0016346517, 0.007280631, -0.038120773, -0.03028533, 0.0009369277, 0.0018615748, -0.011554892, -0.0077461214, 0.014830691, -0.0017432868, 0.039387017, -0.0062065977, -0.0056012236, 0.0066752248, 0.042508006, -0.02434423, 0.008850737, -0.010329139, 0.01011274, -0.013919313, 0.019500017, -0.028813789, 0.0025685977, 0.011436502, -0.017845118, -0.010759781, 0.009633163, -0.002169671, 0.0048031886, 0.022221876, 0.020155473, -0.013638848, 0.023179635, -0.07417797, -0.0070652417, -0.035753112, -0.0055093886, 0.014945317, -0.018100463, -0.026145497, -0.021550441, 0.014085582, 0.0121291075, -0.01628174, -0.019990815, 0.021295896, -0.021369785, 0.009123989, 0.00619617, 0.009404772, 0.00031371464, 0.0070126085, -0.017649213, -0.01789563, -0.015071247, -0.009504008, 0.020647839, -0.0018402728, 0.007850114, -0.025492232, -0.0025770443, -0.009219215, -0.007711371, -0.009867704, -0.15626815, -0.018118573, -0.0061899843, 0.012391243, -0.0086115245, 0.015160283, 0.0061764996, 0.009105368, -0.03564012, -0.003248588, 0.0038347861, -0.014308883, -0.037288513, -0.023459481, 0.01455295, 0.14405149, -0.008769165, 0.013269246, 0.017469807, -0.01574821, 0.0030275187, -0.0021455577, -0.00791672, -0.022986561, -0.0068112183, 0.015397182, 0.017672671, -0.004018052, 0.021046905, 0.0037480847, 0.035376906, 0.0003834399, 0.022733351, -0.00989074, -0.008463355, -0.011889164, -0.006013898, -0.01127539, 0.009397055, -0.035661355, 0.023767805, 0.021820912, 0.003797527, 0.009843469, -0.00041958527, -0.0033223731, -0.010887884, 0.0043569678, -0.018902138, 0.009036769, -0.017339788, -0.0777211, 0.00524885, -0.004221823, 0.014680711, -0.012670116, -0.023653641, -0.020058071, -0.013071862, -0.0014081375, 0.012618809, -0.0006620207, -0.012231201, 0.0036625552, -0.011805273, -0.006003481, 0.03134086, -0.0071307756, -0.020362778, 0.0002620259, -0.013597785, 0.012033703, -0.015461154, -0.0042689727, 0.012692888, -0.026355784, -0.02850368, -0.0043670954, 0.046040278, -0.003550651, 0.009804571, -0.011433284, 0.037872676, 0.008496448, -0.015804999, -0.01797998, 0.008449476, -0.0037801198, 0.005934543, 0.02435972, 0.026647266, -0.0016327054, -0.003541112, -0.0064111413, -0.008512924, 0.00035444152, 0.007476088, 0.012863847, -0.019365743, -0.01385807, 0.01443076, -0.00449911, 0.0072624707, -0.016951898, 0.006832968, -0.02713059, 0.0005089356, 0.017047528, 0.042714365, 0.017579272 ], "ai_confidence_score": 0.9999999999999999, "ai_extraction_metadata": { "extracted_at": "2026-02-15T16:56:05.711477Z", "ai_model": "gemini-2.0-flash-lite", "extraction_method": "automated", "content_length": 11788, "url": "https:\/\/www.politico.com\/newsletters\/politico-pulse\/2024\/04\/24\/pharma-lobbying-up-in-2024-00153996", "existing_metadata": { "author_name": null, "published_at": null, "domain_name": null, "site_name": null, "section": null, "publisher": null } } } - Database ID
- 4270
- UUID
- 9f9a438d-7ec5-4c71-8467-e979e0bb9ddd
- Submitted By User ID
- 7
- Created At
- August 10, 2025 at 6:04 PM
- Updated At
- February 15, 2026 at 4:56 PM
- AI Source Vector
-
Vector length: 768
View Vector Data
[ -0.009589121, -0.00027926627, 0.0024956907, -0.054454945, -0.0054307603, 0.001639773, -0.026273513, 0.04006247, -0.011948857, 0.013991365 ]... (showing first 10 of 768 values) - AI Extraction Metadata
-
{ "extracted_at": "2026-02-15T16:56:05.711477Z", "ai_model": "gemini-2.0-flash-lite", "extraction_method": "automated", "content_length": 11788, "url": "https:\/\/www.politico.com\/newsletters\/politico-pulse\/2024\/04\/24\/pharma-lobbying-up-in-2024-00153996", "existing_metadata": { "author_name": null, "published_at": null, "domain_name": null, "site_name": null, "section": null, "publisher": null } } - Original Content
-
<html lang="en" class="no-js"><!--<![endif]--><head><script id="twitter-wjs" async="" src="//platform.twitter.com/widgets.js"></script><script async="" data-jsonpid="63001638" src="https://cdn-gl.imrworldwide.com/novms/js/2/nlsSDK600.bundle.min.js"></script><script id="NZD0M0OBz2-7bntA9GZmnQ6AMFI" async="" src="//cdn.confiant-integrations.net/gptprebidnative/202508051250/wrap.js"></script><script async="" src="//cdn.confiant-integrations.net/ast/202507101544/wrap.js"></script><meta http-equiv="origin-trial" content="A7vZI3v+Gz7JfuRolKNM4Aff6zaGuT7X0mf3wtoZTnKv6497cVMnhy03KDqX7kBz/q/iidW7srW31oQbBt4VhgoAAACUeyJvcmlnaW4iOiJodHRwczovL3d3dy5nb29nbGUuY29tOjQ0MyIsImZlYXR1cmUiOiJEaXNhYmxlVGhpcmRQYXJ0eVN0b3JhZ2VQYXJ0aXRpb25pbmczIiwiZXhwaXJ5IjoxNzU3OTgwODAwLCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="> <meta charset="utf-8"> <link rel="canonical" href="https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996"><meta name="brightspot.c... - Parsed Content
-
Print Chelsea is a reporter at POLITICO, with a focus on HHS. She also co-authors Pulse, POLITICO's flagship morning health newsletter. She's been a health care reporter since 2019, having started her career at Inside Health Policy. She previously worked for U.S. News & World Report and Axios. She is also an adjunct journalism professor at the University of Maryland and her alma mater, American University, which she graduated from in 2017 with a degree in communications. Ben is a congressional reporter at POLITICO, focusing on domestic policy, with an emphasis on the House Energy and Commerce Committee and related Senate committees including the Senate Commerce Committee and the Senate Committee on Health, Education, Labor and Pensions.His coverage on policy issues is read closely by policymakers and company executives.He's spent years covering the ins and outs of health care policy on Capitol Hill, breaking a steady stream of scoop...
Processing Status Details
Detailed status of each processing step.
- Pipeline Status
-
Completed Started: Feb 15, 2026 4:55 PM Completed: Feb 15, 2026 4:57 PM
- AI Extraction Status
-
Pending
Re-evaluate with Updated AI
Re-process this source with the latest AI models and improved claim extraction algorithms. This will update the AI analysis and extract new claims without re-scraping the content.
Claims from this Source (21)
All claims extracted from this source document.
-
π€ The author π News Article π a1165f68-5757-4f30-bcf7-5199b9fbfc65Simplified: Drugmakers ramped up K Street spending this year
-
π€ The author π News Article π a1165f69-0716-4e4f-8b9d-f6096995fbc1Simplified: Novartis spent 44 percent more on lobbying last quarter than in 2023
-
π€ The author π News Article π a1165f69-4450-49be-bea2-2082dcde99d0Simplified: The industry was working on issues advancing in Congress
-
π€ The author π News Article π a1165f6a-03e1-496b-a948-614c3e8ae89bSimplified: The Pharmaceutical Care Management Association increased lobbying spending by 74 percent compared to last year
-
π€ The author π News Article π a1165f6a-2625-486b-b2f0-dc5ad5873989Simplified: Negotiations over policy riders ultimately fell apart
-
The Supreme Court will hear arguments today on whether Idaho's abortion ban is constitutional.0.950π€ The author π News Article π a1165f6a-4503-43a7-8eee-e6ede0fa3be2Simplified: Supreme Court will hear arguments today on whether Idaho's abortion ban is constitutional
-
Simplified: Ruling for Idaho could encourage states hospitals to test bounds of EMTALA for care unrelated to abortion
-
Simplified: FDA said commercial milk supply is safe after bird flu virus fragments detected in retail milk samples
-
π€ The author π News Article π·οΈ Health , Statistical π a1165f6b-79d0-4e76-ac31-ecb78d994411Simplified: As of Tuesday avian flu detected in 33 dairy herds across eight states according to latest USDA data
-
π€ The author π News Article π·οΈ Health , Statistical π a1165f6b-a2d1-4e00-ac8c-38d9bfc446a0Simplified: One in 4 Medicare beneficiaries overweight or obese might be eligible for Wegovy coverage
-
π€ The author π News Article π·οΈ Health , Regulatory π a1165f6b-cf00-4b35-8d72-78d4eca3eb47Simplified: FDA approved Novo Nordisk's Wegovy to reduce risk of major cardiovascular deaths in people with heart disease
-
Simplified: CMS announced in March Medicare would reimburse older Americans prescribed Wegovy under those conditions
-
π€ The author π News Article π·οΈ Health , Statistical π a1165f6c-39d5-4e5b-9d98-33d3f3bbaa6bSimplified: 20 percent of Medicare beneficiaries or 10 million people had cardiovascular disease in 2020 while 27 percent or 137 million people were obese or over...
-
Simplified: Medicare is prohibited by law from covering weight-loss drugs solely for obesity
-
π€ The author π News Article π·οΈ Legal , Regulatory π a1165f6c-8e4f-4721-be2f-10e49d2d1de3Simplified: Hospital groups expected to challenge FTC rule banning noncompete agreements for all workers
-
π€ The author π News Article π·οΈ Legal , Regulatory π a1165f6c-b684-4689-8b36-b92c4c42319aSimplified: Rule declares noncompetes an unfair method of competition
-
π€ The author π News Article π·οΈ Legal , Regulatory π a1165f6c-fa19-4f5e-80fa-ada3ca0a2fb2Simplified: Doctors will benefit from decision since 45 percent in group practices are bound by noncompetes
-
π€ The author π News Article π·οΈ Legal , Regulatory π a1165f6d-49a9-475c-a969-973480a90b50Simplified: U S Chamber of Commerce other groups expected to sue Chamber saying it would challenge FTC's authority to issue rule as soon as Wednesday
-
Simplified: Teal Baker has joined Better Medicare Alliance as chief operating officer